These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
170 related articles for article (PubMed ID: 36299197)
1. [Mechanism and clinical significance of HBV reactivation after anti-HCV therapy]. Zeng WJ; Gao L; Xu YW; Chen XM; Wang FS; Lu FM Zhonghua Gan Zang Bing Za Zhi; 2022 Sep; 30(9):997-1001. PubMed ID: 36299197 [TBL] [Abstract][Full Text] [Related]
2. Hepatitis B virus (HBV) reactivation-The potential role of direct-acting agents for hepatitis C virus (HCV). Blackard JT; Sherman KE Rev Med Virol; 2018 Jul; 28(4):e1984. PubMed ID: 29761585 [TBL] [Abstract][Full Text] [Related]
3. Direct-acting antivirals and hepatitis B virus (HBV) reactivation in co-infected HBV/HCV kidney-transplant recipients. Pol S; Marion O; Vallet-Pichard A; Meritet JF; Sauné K; Alric L; Kamar N Transpl Infect Dis; 2018 Jun; 20(3):e12864. PubMed ID: 29512231 [TBL] [Abstract][Full Text] [Related]
4. HBV reactivation in patients with HCV/HBV cirrhosis on treatment with direct-acting antivirals. Calvaruso V; Ferraro D; Licata A; Bavetta MG; Petta S; Bronte F; Colomba G; Craxì A; Di Marco V J Viral Hepat; 2018 Jan; 25(1):72-79. PubMed ID: 28703895 [TBL] [Abstract][Full Text] [Related]
5. Hepatitis C Virus and Hepatitis B Virus Co-Infection. Shih YF; Liu CJ Viruses; 2020 Jul; 12(7):. PubMed ID: 32664198 [TBL] [Abstract][Full Text] [Related]
6. Hepatitis B Reactivation in Patients Treated with Direct-Acting Antivirals for Hepatitis C. Toka B; Köksal AŞ; Dertli R; Şirin G; Fidan S; Ülger Y; Harmandar F; Yıldırım AE; Eminler AT; Asil M; Kayar Y; Bıyık M; Kuran S; Uslan MI; Hülagü S Dig Dis; 2022; 40(5):635-643. PubMed ID: 35108715 [TBL] [Abstract][Full Text] [Related]
7. Hepatitis B Virus (HBV) Reactivation Following Pharmacological Eradication of Hepatitis C Virus (HCV). Pisaturo M; Macera M; Alessio L; Calò F; Coppola N Viruses; 2019 Sep; 11(9):. PubMed ID: 31540223 [TBL] [Abstract][Full Text] [Related]
8. Serum IL-1β predicts de novo hepatitis B virus reactivation during direct-acting antiviral therapy for hepatitis C, not during anti-cancer/immunosuppressive therapy. Kawagishi N; Suda G; Sakamori R; Matsui T; Onozawa M; Yang Z; Yoshida S; Ohara M; Kimura M; Kubo A; Maehara O; Fu Q; Hosoda S; Tokuchi Y; Suzuki K; Nakai M; Sho T; Morikawa K; Natsuizaka M; Ogawa K; Sakai H; Ohnishi S; Baba M; Takehara T; Sakamoto N Sci Rep; 2022 Oct; 12(1):16800. PubMed ID: 36207368 [TBL] [Abstract][Full Text] [Related]
9. Hepatitis B virus reactivation after treatment for hepatitis C in hemodialysis patients with HBV/HCV coinfection. Wahle RC; Perez RM; Pereira PF; Oliveira EM; Emori CT; Uehara SN; Silva IS; Silva AE; Ferraz ML Braz J Infect Dis; 2015; 19(5):533-7. PubMed ID: 25997784 [TBL] [Abstract][Full Text] [Related]
10. Risk of hepatitis B reactivation in patients treated with direct-acting antivirals for hepatitis C. Aggeletopoulou I; Konstantakis C; Manolakopoulos S; Triantos C World J Gastroenterol; 2017 Jun; 23(24):4317-4323. PubMed ID: 28706414 [TBL] [Abstract][Full Text] [Related]
11. Serum cytokine/chemokine profiles predict hepatitis B reactivation in HBV/HCV co-infected subjects receiving direct-acting antiviral agents. Huang SC; Cheng PN; Liu CH; Yang HC; Su TH; Tseng TC; Chen PJ; Kao JH; Liu CJ J Formos Med Assoc; 2022 May; 121(5):920-929. PubMed ID: 34538552 [TBL] [Abstract][Full Text] [Related]
12. Risk of hepatitis B virus reactivation with direct-acting antivirals against hepatitis C virus: A cohort study from Egypt and meta-analysis of published data. El Kassas M; Shimakawa Y; Ali-Eldin Z; Funk AL; Wifi MN; Zaky S; El-Raey F; Esmat G; Fontanet A Liver Int; 2018 Dec; 38(12):2159-2169. PubMed ID: 29738637 [TBL] [Abstract][Full Text] [Related]
13. Advances in the treatment of hepatitis B virus/hepatitis C virus coinfection. Sagnelli E; Pisaturo M; Martini S; Sagnelli C; Filippini P; Coppola N Expert Opin Pharmacother; 2014 Jul; 15(10):1337-49. PubMed ID: 24773464 [TBL] [Abstract][Full Text] [Related]
14. The burden of HBV infection in HCV patients in Italy and the risk of reactivation under DAA therapy. Stroffolini T; Sagnelli E; Sagnelli C; Smedile A; Furlan C; Morisco F; Coppola N; Andriulli A; Almasio PL Dig Liver Dis; 2019 Mar; 51(3):434-437. PubMed ID: 30361062 [TBL] [Abstract][Full Text] [Related]
15. Hepatitis B Virus Reactivation Associated With Direct-Acting Antiviral Therapy for Chronic Hepatitis C Virus: A Review of Cases Reported to the U.S. Food and Drug Administration Adverse Event Reporting System. Bersoff-Matcha SJ; Cao K; Jason M; Ajao A; Jones SC; Meyer T; Brinker A Ann Intern Med; 2017 Jun; 166(11):792-798. PubMed ID: 28437794 [TBL] [Abstract][Full Text] [Related]
16. Direct-acting antiviral treatment in adults infected with hepatitis C virus: Reactivation of hepatitis B virus coinfection as a further challenge. De Monte A; Courjon J; Anty R; Cua E; Naqvi A; Mondain V; Cottalorda J; Ollier L; Giordanengo V J Clin Virol; 2016 May; 78():27-30. PubMed ID: 26967675 [TBL] [Abstract][Full Text] [Related]
17. Pharmacotherapeutic strategies for hepatitis B and hepatitis C coinfection. Jacob R; Danta M Expert Opin Pharmacother; 2022 Mar; 23(4):465-472. PubMed ID: 34937470 [TBL] [Abstract][Full Text] [Related]
18. Hepatitis B virus coinfection in patients treated for chronic hepatitis C: clinical characteristics, risk of reactivation with long-term follow-up, and effectiveness of antiviral therapy. Zarębska-Michaluk D; Brzdęk M; Rzymski P; Dobrowolska K; Flisiak R Pol Arch Intern Med; 2024 Jan; 134(1):. PubMed ID: 38164525 [TBL] [Abstract][Full Text] [Related]
19. When viruses collide: hepatitis B virus reactivation after hepatitis C treatment. Balagopal A; Thio CL J Clin Invest; 2020 Jun; 130(6):2823-2826. PubMed ID: 32420916 [TBL] [Abstract][Full Text] [Related]
20. Hepatitis B virus reactivation during direct-acting antiviral therapy for hepatitis C: a systematic review and meta-analysis. Mücke MM; Backus LI; Mücke VT; Coppola N; Preda CM; Yeh ML; Tang LSY; Belperio PS; Wilson EM; Yu ML; Zeuzem S; Herrmann E; Vermehren J Lancet Gastroenterol Hepatol; 2018 Mar; 3(3):172-180. PubMed ID: 29371017 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]